IN2012DN00569A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN00569A IN2012DN00569A IN569DEN2012A IN2012DN00569A IN 2012DN00569 A IN2012DN00569 A IN 2012DN00569A IN 569DEN2012 A IN569DEN2012 A IN 569DEN2012A IN 2012DN00569 A IN2012DN00569 A IN 2012DN00569A
- Authority
- IN
- India
- Prior art keywords
- motilin
- maintain
- native
- activity
- transmucosal administration
- Prior art date
Links
- LVRVABPNVHYXRT-BQWXUCBYSA-N 52906-92-0 Chemical compound C([C@H](N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)C(C)C)C1=CC=CC=C1 LVRVABPNVHYXRT-BQWXUCBYSA-N 0.000 abstract 6
- 101800002372 Motilin Proteins 0.000 abstract 5
- 102000002419 Motilin Human genes 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 230000015556 catabolic process Effects 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000005176 gastrointestinal motility Effects 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- 230000037361 pathway Effects 0.000 abstract 1
- 230000001766 physiological effect Effects 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/63—Motilins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nutrition Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention aims at providing motilin-like peptide compounds that maintain the gastrointestinal motility stimulating activity of native motilin and which are adapted to have higher absorbability upon transmucosal administration. Motilin derivatives were designed and synthesized in consideration of the pathway for the degradation of motilin at a site of its transmucosal absorption and the maintenance of motilin's physiological activity and compounds characterized by substitutions for the amino acid at position 21 of native motilin have been found to show higher absorbability upon transmucosal administration and yet maintain the same activity as motilin.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009177107 | 2009-07-29 | ||
| PCT/JP2010/062746 WO2011013728A1 (en) | 2009-07-29 | 2010-07-29 | Motilin-like peptide compound having transmucosal absorbability imparted thereto |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN00569A true IN2012DN00569A (en) | 2015-06-12 |
Family
ID=43529381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN569DEN2012 IN2012DN00569A (en) | 2009-07-29 | 2010-07-29 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8710184B2 (en) |
| EP (1) | EP2460826B1 (en) |
| JP (1) | JP5647609B2 (en) |
| KR (1) | KR101789605B1 (en) |
| CN (1) | CN102574904B (en) |
| AU (1) | AU2010279076B2 (en) |
| BR (1) | BR112012000719A2 (en) |
| CA (1) | CA2769013C (en) |
| CO (1) | CO6430471A2 (en) |
| ES (1) | ES2653523T3 (en) |
| IL (1) | IL217781A (en) |
| IN (1) | IN2012DN00569A (en) |
| MX (1) | MX2012001193A (en) |
| MY (1) | MY161842A (en) |
| NZ (1) | NZ597777A (en) |
| PH (1) | PH12012500169A1 (en) |
| RU (1) | RU2540012C2 (en) |
| SG (1) | SG177592A1 (en) |
| TW (1) | TWI471138B (en) |
| WO (1) | WO2011013728A1 (en) |
| ZA (1) | ZA201200440B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20130010462A (en) * | 2010-03-19 | 2013-01-28 | 다이이찌 산쿄 가부시키가이샤 | Composition for transnasal administration and method for producing same |
| CA2919583C (en) * | 2013-07-31 | 2018-09-11 | Rinat Neuroscience Corp. | Engineered polypeptide conjugates |
| KR101470793B1 (en) * | 2014-06-30 | 2014-12-08 | 순천향대학교 산학협력단 | Peptide as permeation enhancer and composition including the same |
| RU2662310C9 (en) | 2015-12-04 | 2018-09-21 | Виктор Вениаминович Тец | Means (options) and methods of microflora recovery |
| CN107383169A (en) * | 2017-04-24 | 2017-11-24 | 青岛大学 | A kind of polypeptide with gastrointestinal motility stimulating activity |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2544348C3 (en) | 1975-10-03 | 1979-12-13 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen | L-leucine-13-motiline, process for its preparation and agent containing the same |
| JP2753274B2 (en) * | 1988-08-24 | 1998-05-18 | 株式会社三和化学研究所 | Method for producing motilin-like polypeptide, recombinant DNA therefor and plasmid for expression |
| JPH0742319B2 (en) * | 1989-01-06 | 1995-05-10 | 株式会社三和化学研究所 | Polypeptide having motilin-like activity and use thereof |
| EP0378078A1 (en) * | 1989-01-06 | 1990-07-18 | Sanwa Kagaku Kenkyusho Co., Ltd. | Motilin-like polypeptide and use thereof |
| DE3922764A1 (en) | 1989-07-11 | 1991-01-17 | Babcock Werke Ag | METHOD AND DEVICE FOR SEPARATING SOLID FROM A GAS |
| JPH04364131A (en) | 1991-04-03 | 1992-12-16 | Sanwa Kagaku Kenkyusho Co Ltd | Readily absorbable motiline pharmaceutical preparation |
| US5422341A (en) | 1993-08-06 | 1995-06-06 | Ohmeda Pharmaceutical Products Division Inc. | Motilin-like polypeptides with gastrointestinal motor stimulating activity |
| NZ337958A (en) * | 1997-03-24 | 2001-03-30 | Zymogenetics Inc | Motilin homolog designated zsig33 for treating gastrointestinal cell contractility, secretion of digestive enzymes, gastrointestinal motility, recruitment of digestive enzymes, reflux disease and regulation of nutrient absorption |
| US5972939A (en) * | 1997-10-28 | 1999-10-26 | Ortho-Mcneil Pharmaceutical, Inc. | Cyclopentene derivatives useful as antagonists of the motilin receptor |
| SE9802080D0 (en) * | 1998-06-11 | 1998-06-11 | Hellstroem | Pharmaceutical composition for the treatment of functional dyspepsia and / or irritable bowel syndrome and new use of substances therein |
| US6849714B1 (en) * | 1999-05-17 | 2005-02-01 | Conjuchem, Inc. | Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| US6887470B1 (en) * | 1999-09-10 | 2005-05-03 | Conjuchem, Inc. | Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| CA2499211A1 (en) * | 1999-05-17 | 2000-11-23 | Conjuchem Inc. | Modified peptides yy and conjugates thereof |
| US6511980B2 (en) * | 2000-05-05 | 2003-01-28 | Ortho Mcneil Pharmaceutical, Inc. | Substituted diamine derivatives useful as motilin antagonists |
| RU2252779C1 (en) * | 2003-09-23 | 2005-05-27 | Институт Молекулярной Генетики Российской Академии Наук (Имг Ран) | Method for preventing and treating ulcers of gastro-intestinal tract |
| KR20130010462A (en) | 2010-03-19 | 2013-01-28 | 다이이찌 산쿄 가부시키가이샤 | Composition for transnasal administration and method for producing same |
-
2010
- 2010-07-29 NZ NZ597777A patent/NZ597777A/en not_active IP Right Cessation
- 2010-07-29 BR BR112012000719A patent/BR112012000719A2/en not_active Application Discontinuation
- 2010-07-29 CN CN201080043683.9A patent/CN102574904B/en not_active Expired - Fee Related
- 2010-07-29 IN IN569DEN2012 patent/IN2012DN00569A/en unknown
- 2010-07-29 SG SG2012001715A patent/SG177592A1/en unknown
- 2010-07-29 US US13/388,021 patent/US8710184B2/en not_active Expired - Fee Related
- 2010-07-29 MY MYPI2012000392A patent/MY161842A/en unknown
- 2010-07-29 KR KR1020127002980A patent/KR101789605B1/en not_active Expired - Fee Related
- 2010-07-29 TW TW99125019A patent/TWI471138B/en not_active IP Right Cessation
- 2010-07-29 AU AU2010279076A patent/AU2010279076B2/en not_active Ceased
- 2010-07-29 MX MX2012001193A patent/MX2012001193A/en active IP Right Grant
- 2010-07-29 ES ES10804474.4T patent/ES2653523T3/en active Active
- 2010-07-29 RU RU2012107290/10A patent/RU2540012C2/en not_active IP Right Cessation
- 2010-07-29 WO PCT/JP2010/062746 patent/WO2011013728A1/en active Application Filing
- 2010-07-29 PH PH1/2012/500169A patent/PH12012500169A1/en unknown
- 2010-07-29 CA CA2769013A patent/CA2769013C/en not_active Expired - Fee Related
- 2010-07-29 JP JP2011524821A patent/JP5647609B2/en not_active Expired - Fee Related
- 2010-07-29 EP EP10804474.4A patent/EP2460826B1/en not_active Not-in-force
-
2012
- 2012-01-19 ZA ZA2012/00440A patent/ZA201200440B/en unknown
- 2012-01-26 IL IL217781A patent/IL217781A/en not_active IP Right Cessation
- 2012-02-13 CO CO12024411A patent/CO6430471A2/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| RU2012107290A (en) | 2013-09-10 |
| MX2012001193A (en) | 2012-03-14 |
| KR101789605B1 (en) | 2017-10-25 |
| CN102574904B (en) | 2014-11-26 |
| SG177592A1 (en) | 2012-02-28 |
| EP2460826B1 (en) | 2017-10-18 |
| AU2010279076A1 (en) | 2012-03-01 |
| IL217781A (en) | 2015-09-24 |
| IL217781A0 (en) | 2012-03-29 |
| ZA201200440B (en) | 2013-04-24 |
| MY161842A (en) | 2017-05-15 |
| WO2011013728A1 (en) | 2011-02-03 |
| US8710184B2 (en) | 2014-04-29 |
| NZ597777A (en) | 2013-03-28 |
| JPWO2011013728A1 (en) | 2013-01-10 |
| CO6430471A2 (en) | 2012-04-30 |
| PH12012500169A1 (en) | 2019-07-10 |
| ES2653523T3 (en) | 2018-02-07 |
| AU2010279076B2 (en) | 2014-09-25 |
| JP5647609B2 (en) | 2015-01-07 |
| EP2460826A1 (en) | 2012-06-06 |
| CA2769013A1 (en) | 2011-02-03 |
| US20120129762A1 (en) | 2012-05-24 |
| CA2769013C (en) | 2015-04-07 |
| BR112012000719A2 (en) | 2016-11-01 |
| TWI471138B (en) | 2015-02-01 |
| KR20120052274A (en) | 2012-05-23 |
| CN102574904A (en) | 2012-07-11 |
| EP2460826A4 (en) | 2013-11-20 |
| RU2540012C2 (en) | 2015-01-27 |
| TW201106964A (en) | 2011-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2011008634A (en) | Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy. | |
| BR112012013431A2 (en) | compound, pharmaceutical composition and its use | |
| EA201171088A1 (en) | TREATMENT OF DISKINESIA IN DIFFERENT DISORDERS | |
| TNSN08326A1 (en) | Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments | |
| CL2013003406A1 (en) | Compounds derived from dolastatin bound to unnatural amino acids; preparation procedure; Pharmaceutical compositions, useful in the treatment of breast cancer. | |
| PE20121617A1 (en) | OXAZINE DERIVATIVES AS BACE INHIBITORS | |
| IN2012DN02736A (en) | ||
| WO2012020131A3 (en) | Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy | |
| PH12013500473A1 (en) | Triazine-oxadiazoles | |
| PL2229938T3 (en) | Ezetimibe compositions | |
| IN2012DN06720A (en) | ||
| TN2011000437A1 (en) | Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof | |
| UA105229C2 (en) | Pharmaceutical formulation | |
| TN2011000172A1 (en) | Therapeutic antiviral peptides | |
| WO2011047173A3 (en) | Pharmaceutical compositions for oral administration | |
| UA105018C2 (en) | Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition | |
| CR20110255A (en) | NEW COMPOUNDS 578 | |
| IN2012DN02139A (en) | ||
| MY149854A (en) | Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments | |
| IN2012DN00569A (en) | ||
| MY164864A (en) | Indenone derivative and pharmaceutical composition comprising same | |
| MX2011008627A (en) | Methods of administering (4ar, 1oar)-i-n-propyl-i, 2,3,4a7 s1io7 ioa-octahydrobenzo [g] quinoline-6,7-diol and related compounds across the oral mucosa, the nasal mucosa or the skin and pharmaceutical compositions thereof. | |
| IN2012DN02502A (en) | ||
| BRPI0917245B8 (en) | isoquinolinone derivative compounds and their pharmaceutical composition | |
| MX2012002369A (en) | Anhydrate forms of a pyridine derivative. |